Sell Recommendation for Medtronic (MDT) Shares Retained

Currently, Medtronic Plc (NYSE:MDT) has a Sell using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. The current Portfolio Grader recommendation on the shares has been in place for 4 months.

The company ranks in the top 10% of its industry group, Health Care Equipment & Supplies, and in the top 10% of its sector group, Health Care, with a market value of $109.6 billion.

Currently, Portfolio Grader ranks the Health Care sector number 8 among the 12 sectors in its universe putting it in the third quartile of all the GICS sectors. The Health Care Equipment & Supplies industry group is ranked 44 among the 69 industry groups within the GICS sectors, placing it below-average in terms of the Navellier scoring system.

The scores the company has achieved are average or below-average scores in 6 of the 8 areas analyzed by Portfolio Grader in the ranking of company stocks.

The company's operational scores provide mixed results with rankings for operating margin and earnings growth that are above average, while the score for sales growth is below average. Scores for visibility of earnings are worse than the industry norms for earnings revisions, earnings surprises, and earnings momentum. MDT's metrics for return on equity and cash flow are worse than its industry group average. Based on these fundamental scores, Medtronic places in the top half of the industry group.

Portfolio Grader quantitatively measures MDT's shares using the Navellier Proprietary Quantitative Score. This metric looks at MDT's shares from the angle of risk/reward. This proprietary scoring system considers the relative value of MDT's shares based on the current price of the shares relative to its peers, the market and risk associated with its industry and sector groups. Using this risk/reward calculation, the company currently scores below-average in its industry group compared to its peers.

Louis Navellier's proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results, with A being 'strong buy' and F being 'strong sell'. Explore the tool here.

Commentary provided by UpTick Data Technologies.


Article printed from InvestorPlace Media, https://investorplace.com/2017/10/sell-recommendation-for-medtronic-mdt-shares-retained/.

©2026 InvestorPlace Media, LLC